comparemela.com

Latest Breaking News On - Hils l - Page 2 : comparemela.com

ULS Technology agrees partnership with MPowered Mortgages | 28 May 2021

28 May 2021 | 09:26am StockMarketWire.com - ULS Technology, the provider of online B2B platforms for the UK conveyancing and financial intermediary markets, has agreed a partnership with MPowered Mortgages to provide an integrated panel management service to the recently launched lender. The integrated service will provide MPowered Mortgages with access to ULS Technology s full solicitor panel, enabling the lender to deliver electronic Offers and Certificates of Title to customers in line with its digitally-focused approach to lending. This is the latest lender partnership announced by ULS Technology which provides full back-office panel management services for lenders to better manage the risk, security and speed of their transactions. Existing partnerships include Principality Building Society, Hodge, Habito and, most recently, Foundation Home Loans.

Director Deals - (ULS) | 27 May 2021 | Stock Market Wire

Director Deals 27 May 2021 | 06:10am StockMarketWire.com - Oliver Scott, Non Executive Director, has transferred out 716,410 shares in the company on the 25th May 2021 at a price of £0.00. The Director now holds 17,678,424 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.uk Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details:

Tiziana Life Sciences doses first patient in MS treatment trial | 25 May 2021

25 May 2021 | 09:51am StockMarketWire.com - Inflammatory diseases and cancer focused Tiziana Life Sciences said the first patient with secondary progressive multiple sclerosis was dosed in a treatment trial. The trial was testing nasally administered Foralumab, a fully human anti-CD3 monoclonal antibody, at the Brigham and Women s Hospital, Harvard Medical School, Boston, MA. This clinical study would continue for six months to evaluate routine safety, tolerability, and neurological behaviours. It also would examine microglial activation, immunological and neurodegenerative markers to assess clinical responses following the treatment regimen. At 9:51am: [LON:TILS] Tiziana Life Sciences Plc share price was 0p at 92p

FTSE opens flat after Fed tempers inflation fears | 25 May 2021

25 May 2021 | 08:37am StockMarketWire.com - UK stocks tracked sideways in early trading on Tuesday after US Federal Reserve officials cooled inflation fears, though a strengthening of the pound against the dollar weighed on exporters. At 0825, the benchmark FTSE 100 index was down just 1.25 points at 7,050.34. Industrial software group Aveva rallied 4.2% to £34.14 even as it reported a 63% slump in annual profit after the pandemic hits sales in the first half. Aveva nevertheless upped its dividend by 1% to 23.5p per share, citing a second-half sales recovery that had limited a full-year fall in revenue to just 1.4%. Engineering group Smiths fell 1.2% to £15.41 on announcing that chief executive Andy Reynolds Smith had stood down with immediate effect and been replaced by former 3M executive Paul Keel.

Hill & Smith makes good start to year as revenue rises 10% in first four months | 25 May 2021

25 May 2021 | 07:43am StockMarketWire.com - Infrastructure and safe transport group Hill & Smith said it was had made a good start to the year as revenue rose 10% in the first fourth months from a year earlier. The company also also reported a strong recovery in operating profit in comparison to the same period last year which was impacted by COVID-19 related disruption from the middle of March 2020. The 2020 final dividend of 17.5 pence per share, if approved at the AGM on 25 May, would be paid on 9 July 2021 to those shareholders on the register at close of business on 4 June 2021. Looking ahead, the company said it expected to see a good recovery in trading in 2021 and while mindful of foreign exchange movements, our expectations for the full year remain unchanged.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.